4LT1.F
Northern Oil and Gas, Inc.
FrankfurtEUREQUITY
Energy
DELAYED
Last price
23.29
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
23.29
Day high
23.29
Day low
22.69
Volume
500
Market cap
$2.48B
P/E (TTM)
—
52W range
15.11 – 26.85
Trailing performance
Returnvs SPY
1W
+10.17%
+11.5%
1M
+21.94%
+18.2%
3M
+21.37%
+18.3%
6M
+1.04%
-10.0%
YTD
+28.50%
+16.2%
1Y
+8.88%
-11.1%
3Y
-37.99%
-112.2%
5Y
+60.40%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 4LT1.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.07M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | LASHER STUART G. Director |
STOCK | 2.41K | $0 | Direct |
| Jun 30, 26 | MEIER LISA G Director |
STOCK | 2.41K | $0 | Direct |
| Jun 30, 26 | AKRADI BAHRAM Director |
STOCK | 6.34K | $0 | Direct |
| Jun 30, 26 | POMERANTZ JENNIFER S. Director |
STOCK | 3.79K | $0 | Direct |
| Jun 30, 26 | KIMBLE WILLIAM F Director |
STOCK | 2.41K | $0 | Direct |
| Jun 30, 26 | FRANTZ MICHAEL A Director |
STOCK | 2.41K | $0 | Direct |
| Jun 22, 26 | AKRADI BAHRAM Director |
BUY | 25.76K | $499.74K | Direct |
| Mar 31, 26 | LASHER STUART G. Director |
STOCK | 1.50K | $0 | Direct |
| Mar 31, 26 | MEIER LISA G Director |
STOCK | 1.50K | $0 | Direct |
| Mar 31, 26 | AKRADI BAHRAM Director |
STOCK | 3.93K | $0 | Direct |
| Mar 31, 26 | POMERANTZ JENNIFER S. Director |
STOCK | 2.35K | $0 | Direct |
| Mar 31, 26 | KIMBLE WILLIAM F Director |
STOCK | 1.50K | $0 | Direct |
| Mar 31, 26 | FRANTZ MICHAEL A Director |
STOCK | 1.50K | $0 | Direct |
| Mar 31, 26 | EASLEY ROY ERNEST Director |
STOCK | 1.50K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AKRADI BAHRAM |
Director | 1.72M | Stock Award(Grant) |
ALLEN CHAD WILLIAM |
Chief Financial Officer | 83.91K | Stock Award(Grant) |
DIRLAM ADAM A |
President | — | Stock Award(Grant) |
EASLEY ROY ERNEST |
Director | 86.67K | Stock Award(Grant) |
EVANS JAMES B |
Chief Technology Officer | 78.18K | Stock Award(Grant) |
FRANTZ MICHAEL A |
Director | 67.14K | Stock Award(Grant) |
KING JACK E |
Director | 66.77K | Stock Award(Grant) |
LASHER STUART G. |
Director | 368.43K | Stock Award(Grant) |
O'GRADY NICHOLAS L |
Chief Executive Officer | 261.07K | Stock Award(Grant) |
ROMSLO ERIK J |
Officer | 101.76K | Stock Award(Grant) |
Fundamentals
Market cap$2.48B
Enterprise value$5.15B
Revenue (TTM)$2.01B
Gross profit$1.52B
EBITDA$1.20B
Net income$-486.02M
EPS (TTM)$-4.13
Free cash flow$-459.63M
Total cash$47.60M
Total debt$2.72B
Book value / share$16.09
Shares outstanding106.55M
Float103.04M
Short % of float—
Dividend yield6.72%
Beta (5Y)0.73
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.22
PEG ratio7.32
Price / sales—
Price / book1.45
EV / revenue2.56
EV / EBITDA4.29
Gross margin75.40%
Operating margin57.06%
Profit margin-24.15%
Return on equity-22.05%
Return on assets4.60%
Debt / equity136.56
Current ratio0.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.10B | $2.16B | $1.91B | $1.99B | -3.2% |
| Operating revenue | $2.08B | $2.15B | $1.90B | $1.99B | -3.3% |
| Cost of revenue | $1.42B | $1.33B | $993.15M | $670.14M | +6.9% |
| Gross profit | $675.20M | $835.98M | $913.86M | $1.32B | -19.2% |
| Selling, general & admin | $61.33M | $50.46M | $46.80M | $47.20M | +21.5% |
| Total operating expense | $74.18M | $60.11M | $51.25M | $47.20M | +23.4% |
| Operating income | $601.02M | $775.86M | $862.61M | $1.27B | -22.5% |
| Net interest income | -$172.38M | -$157.72M | -$135.66M | -$80.33M | -9.3% |
| Pre-tax income | $62.70M | $680.82M | $1.00B | $776.34M | -90.8% |
| Tax provision | $23.94M | $160.51M | $77.77M | $3.10M | -85.1% |
| Net income | $38.76M | $520.31M | $922.97M | $773.24M | -92.6% |
| Net income to common | $38.76M | $520.31M | $922.97M | $727.70M | -92.6% |
| Basic EPS | 0.40 | 5.21 | 10.09 | 9.26 | -92.3% |
| Diluted EPS | 0.39 | 5.14 | 10.03 | 8.92 | -92.4% |
| EBIT | $235.09M | $838.53M | $1.14B | $856.67M | -72.0% |
| EBITDA | $1.05B | $1.58B | $1.62B | $1.11B | -33.5% |
| Basic shares | 97.71M | 99.85M | 91.48M | 78.56M | -2.1% |
| Diluted shares | 99.31M | 101.27M | 92.06M | 86.68M | -1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $14.30M | $8.93M | $8.20M | $2.53M | +60.1% |
| Cash & short-term investments | $14.30M | $8.93M | $8.20M | $2.53M | +60.1% |
| Accounts receivable | $349.93M | $389.67M | $370.53M | $271.34M | -10.2% |
| Total current assets | $586.03M | $500.74M | $509.41M | $320.49M | +17.0% |
| Property, plant & equipment | $4.75B | $5.08B | $3.93B | $2.48B | -6.6% |
| Total assets | $5.41B | $5.60B | $4.48B | $2.88B | -3.5% |
| Total current liabilities | $539.29M | $544.27M | $385.76M | $344.97M | -0.9% |
| Long-term debt | $2.40B | $2.37B | $1.84B | $1.53B | +1.1% |
| Total debt | $2.40B | $2.37B | $1.84B | $1.53B | +1.1% |
| Total liabilities | $3.28B | $3.28B | $2.44B | $2.13B | -0.0% |
| Retained earnings | $481.28M | $442.52M | -$77.79M | -$1.00B | +8.8% |
| Shareholder equity | $2.13B | $2.32B | $2.05B | $745.26M | -8.4% |
| Working capital | $46.74M | -$43.53M | $123.65M | -$24.49M | +207.4% |
| Net tangible assets | $2.13B | $2.32B | $2.05B | $745.26M | -8.4% |
| Shares issued | 97.27M | 99.11M | 100.76M | 85.17M | -1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $38.76M | $520.31M | $922.97M | $773.24M | -92.6% |
| Stock-based compensation | $15.36M | $11.97M | $5.66M | $5.66M | +28.4% |
| Change in working capital | $70.06M | -$53.89M | -$106.13M | -$62.40M | +230.0% |
| Operating cash flow | $1.51B | $1.41B | $1.18B | $928.42M | +6.9% |
| Capital expenditure | -$1.25B | -$1.67B | -$1.86B | -$1.36B | +25.2% |
| Investing cash flow | -$1.25B | -$1.67B | -$1.86B | -$1.40B | +25.2% |
| Dividends paid | -$173.40M | -$161.97M | -$123.94M | -$73.27M | -7.1% |
| Financing cash flow | -$247.46M | $266.83M | $684.69M | $467.37M | -192.7% |
| Free cash flow | $252.83M | -$266.09M | -$679.02M | -$431.36M | +195.0% |
| End cash position | $14.30M | $8.93M | $8.20M | $2.53M | +60.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $675.05M | $544.09M | $450.86M | $485.87M | $577.99M | — | +24.1% |
| Operating revenue | $670.80M | $539.86M | $447.72M | $482.24M | $574.37M | — | +24.3% |
| Cost of revenue | $365.67M | $365.19M | $354.92M | $346.36M | $362.79M | — | +0.1% |
| Gross profit | $309.38M | $178.90M | $95.95M | $139.51M | $215.20M | — | +72.9% |
| Selling, general & admin | $24.53M | $23.17M | $17.12M | $14.10M | $15.63M | — | +5.8% |
| Total operating expense | $27.02M | $26.45M | $20.60M | $17.37M | $19.19M | — | +2.2% |
| Operating income | $282.36M | $152.45M | $75.34M | $122.14M | $196.01M | — | +85.2% |
| Net interest income | -$41.44M | -$42.59M | -$41.12M | -$42.98M | -$44.39M | — | +2.7% |
| Pre-tax income | $310.60M | -$695.92M | -$86.06M | -$168.80M | $131.78M | — | +144.6% |
| Tax provision | $73.97M | -$173.07M | -$15.33M | -$39.73M | $32.19M | — | +142.7% |
| Net income | $236.63M | -$522.85M | -$70.73M | -$129.07M | $99.58M | — | +145.3% |
| Net income to common | $236.63M | -$522.85M | -$70.73M | -$129.07M | $99.58M | — | +145.3% |
| Basic EPS | 2.24 | -5.31 | -0.73 | — | 1.02 | 1.41 | +142.2% |
| Diluted EPS | 2.19 | -5.31 | -0.73 | — | 1.00 | 1.39 | +141.2% |
| EBIT | $352.04M | -$653.33M | -$44.94M | -$125.83M | $176.17M | — | +153.9% |
| EBITDA | $544.92M | -$456.23M | $159.14M | $73.52M | $381.91M | — | +219.4% |
| Basic shares | 105.87M | 98.50M | 97.12M | — | 98.06M | 98.56M | +7.5% |
| Diluted shares | 108.09M | 98.50M | 97.12M | — | 99.39M | 99.99M | +9.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $47.60M | $37.04M | $14.30M | $31.65M | $25.86M | +28.5% |
| Cash & short-term investments | $47.60M | $37.04M | $14.30M | $31.65M | $25.86M | +28.5% |
| Accounts receivable | $377.82M | $395.29M | $349.93M | $333.96M | $410.25M | -4.4% |
| Total current assets | $502.10M | $472.90M | $586.03M | $542.48M | $588.36M | +6.2% |
| Property, plant & equipment | $5.29B | $5.02B | $4.75B | $4.94B | $5.09B | +5.4% |
| Total assets | $5.83B | $5.51B | $5.41B | $5.49B | $5.70B | +5.7% |
| Total current liabilities | $630.49M | $899.38M | $539.29M | $495.34M | $488.20M | -29.9% |
| Long-term debt | $2.72B | $2.55B | $2.40B | $2.35B | $2.37B | +6.8% |
| Total debt | $2.72B | $2.55B | $2.40B | $2.35B | $2.37B | +6.8% |
| Total liabilities | $3.83B | $3.73B | $3.28B | $3.25B | $3.29B | +2.7% |
| Retained earnings | $195.06M | -$41.57M | $481.28M | $552.01M | $681.09M | +569.3% |
| Shareholder equity | $2.00B | $1.78B | $2.13B | $2.24B | $2.41B | +11.8% |
| Working capital | -$128.39M | -$426.48M | $46.74M | $47.14M | $100.16M | +69.9% |
| Net tangible assets | $2.00B | $1.78B | $2.13B | $2.24B | $2.41B | +11.8% |
| Shares issued | 106.55M | 105.79M | 97.27M | 97.60M | 97.59M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $236.63M | -$522.85M | -$70.73M | -$129.07M | $99.58M | +145.3% |
| Stock-based compensation | $4.41M | $3.71M | $3.92M | $4.09M | $3.78M | +18.9% |
| Change in working capital | -$32.06M | $26.44M | -$3.93M | $78.86M | -$24.87M | -221.3% |
| Operating cash flow | $321.62M | $323.62M | $312.63M | $423.12M | $362.11M | -0.6% |
| Capital expenditure | -$379.81M | -$634.68M | -$308.07M | -$352.58M | -$327.36M | +40.2% |
| Investing cash flow | -$379.81M | -$634.68M | -$308.07M | -$352.58M | -$327.25M | +40.2% |
| Share buybacks | -$50.05M | $0 | -$7.01M | $0 | -$35.00M | — |
| Dividends paid | -$47.72M | -$44.51M | -$43.70M | -$43.70M | -$44.27M | -7.2% |
| Financing cash flow | $74.23M | $333.81M | -$21.91M | -$64.75M | -$42.58M | -77.8% |
| Free cash flow | -$58.19M | -$311.06M | $4.56M | $70.54M | $34.75M | +81.3% |
| End cash position | $47.60M | $37.04M | $14.30M | $31.65M | $25.86M | +28.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $600.19M | +7.8% |
| Next quarter | — | — | $609.73M | -0.1% |
| Current year | — | — | $2.08B | -15.9% |
| Next year | — | — | $2.39B | +14.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.89%
Held by institutions105.16%
Institutions holding443
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
21.62
+7.73% from price
SMA 20
19.73
+18.07% from price
SMA 50
18.14
+28.42% from price
SMA 100
19.56
+19.08% from price
SMA 200
20.23
+15.11% from price
EMA 12
21.27
+9.47% from price
EMA 26
19.96
+16.66% from price
EMA 50
19.31
+20.62% from price
RSI (14)
77.0
Overbought
MACD (12,26,9)
1.31
Hist 0.39
ATR (14)
0.77
3.32% of price
Realised vol 30D
51.0%
Annualised
Bollinger upper
23.80
20, 2σ
Bollinger lower
15.65
20, 2σ
50 / 200 cross
Death
18.14 vs 20.23
Trend bias
Above 200
+15.11%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.51
Less volatile than market
Correlation to SPY
-0.14
Largely independent
Realised vol 30D
51.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-42.7%
Peak to trough
Max drawdown 5Y
-63.4%
Peak to trough
ATR 14
0.77
3.32% of price
Beta (reported)
0.73
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 14, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Jun 29, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Jun 15, 26 | Raymond James | MAINTAINED | Outperform | Outperform |
| May 22, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| May 21, 26 | Raymond James | DOWNGRADE | Strong Buy | Outperform |
| May 20, 26 | Johnson Rice | DOWNGRADE | Accumulate | Hold |
| Apr 14, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 31, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 24, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| Mar 12, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Mar 11, 26 | Citigroup | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$1.56 / yr
Forward yield6.72%
5-year avg yield3.81%
Payout ratio461.54%
Ex-dividend dateSep 29, 2026
Next pay date—
Last split1:10
Split dateSep 21, 2020
Headlines
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 11m ago
TME Pharma provides update on its activities
GlobeNewswire · 11m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 16m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 16m ago
Board Update
GlobeNewswire · 16m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 16m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 16m ago
Holding(s) in Company
GlobeNewswire · 16m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.